Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD

Background Patients with moderate exacerbations of COPD and the eosinophilic phenotype have better outcomes with prednisolone. Whether this outcome is similar in patients hospitalized with a severe exacerbation of COPD is unclear. We investigated the rate of recovery of eosinophilic and noneosinophi...

書誌詳細
主要な著者:	Bafadhel, M, Greening, NJ, Harvey-Dunstan, TC, Williams, JE, Morgan, MD, Brightling, CE, Hussain, SF, Pavord, ID, Singh, SJ, Steiner, MC
フォーマット:	Journal article
言語:	English
出版事項:	Elsevier 2016

類似資料

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
著者:: Bafadhel, M, 等
出版事項: (2014)

Inhaled glucocorticoids and COPD exacerbations.
著者:: Brightling, C, 等
出版事項: (2015)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
著者:: Shrimanker, R, 等
出版事項: (2017)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
著者:: Eltboli, O, 等
出版事項: (2014)

Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
著者:: Barker, R, 等
出版事項: (2017)

Characterising non-eosinophilic COPD
著者:: Hambleton, K, 等
出版事項: (2015)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
著者:: Siddiqui SH, 等
出版事項: (2018-11-01)

Eosinophils in COPD: just another biomarker?
著者:: Bafadhel, M, 等
出版事項: (2017)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
著者:: Siva R, 等
出版事項: (2014-02-01)

Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
著者:: Bafadhel M, 等
出版事項: (2015-06-01)

Blood eosinophil count and exacerbation risk in patients with COPD.
著者:: Kerkhof, M, 等
出版事項: (2017)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
著者:: Siva, R, 等
出版事項: (2007)

Exacerbations of COPD
著者:: Pavord ID, 等
出版事項: (2016-02-01)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
著者:: Djamin, R, 等
出版事項: (2019)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
著者:: Russell REK, 等
出版事項: (2019-05-01)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
著者:: Siddiqui, S, 等
出版事項: (2018)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
著者:: Bafadhel, M, 等
出版事項: (2018)

Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO
著者:: Camp, J, 等
出版事項: (2018)

Lung microbiome dynamics in COPD exacerbations
著者:: Wang, Z, 等
出版事項: (2016)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
著者:: James Camp, 等
出版事項: (2018-09-01)

Aspergillus fumigatus during stable state and exacerbations of COPD.
著者:: Bafadhel, M, 等
出版事項: (2014)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
著者:: Shrimanker, R, 等
出版事項: (2017)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
著者:: Kerkhof, M, 等
出版事項: (2017)

COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD
著者:: Hamish McAuley, 等
出版事項: (2021-01-01)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations.
著者:: Barker, B, 等
出版事項: (2015)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
著者:: Haldar, P, 等
出版事項: (2009)

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
著者:: Russell, R, 等
出版事項: (2016)

Mepolizumab for eosinophilic COPD
著者:: Sciurba, F, 等
出版事項: (2018)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
著者:: Howell, I, 等
出版事項: (2024)

Stability in eosinophil categorisation during subsequent severe exacerbations of COPD
著者:: Huib A M Kerstjens, 等
出版事項: (2021-01-01)

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
著者:: Claus F. Vogelmeier, 等
出版事項: (2019-08-01)

COPD exacerbations: transforming outcomes through research
著者:: Hurst, JR, 等
出版事項: (2018)

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.
著者:: Bafadhel, M, 等
出版事項: (2012)

Investigating blood eosinophil count thresholds in patients with COPD
著者:: Russell, R, 等
出版事項: (2018)

The significance of eosinophilic inflammation in COPD
著者:: Cooper, C, 等
出版事項: (2017)

Variability of blood eosinophil count and prognosis of COPD exacerbations
著者:: Sandra Martínez-Gestoso, 等
出版事項: (2021-01-01)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
著者:: Green, R, 等
出版事項: (2002)

Eosinophils in asthma and airway hyperresponsiveness.
著者:: Brightling, C, 等
出版事項: (2004)

Building toolkits for COPD exacerbations: lessons from the past and present
著者:: Sapey, E, 等
出版事項: (2019)

Is it time to give up on "self-management" of COPD exacerbations?
著者:: Ramakrishnan, S, 等
出版事項: (2020)